Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · IEX Real-Time Price · USD

491.57

+3.45 (0.71%)

At close: Jul 19, 2024, 4:00 PM

494.99

+3.42 (0.70%)

Pre-market: Jul 22, 2024, 8:01 AM EDT

Vertex Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Net Income	4,019	3,620	3,322	2,342	2,712	1,177	Upgrade
Depreciation & Amortization	196	181.3	148.3	125.6	109.5	106.9	Upgrade
Share-Based Compensation	650.7	581.2	491.3	441.4	429.5	360.5	Upgrade
Other Operating Activities	-922.1	-844.8	168.3	-265.6	2.8	-74.9	Upgrade
Operating Cash Flow	3,944	3,537	4,130	2,644	3,254	1,569	Upgrade
Operating Cash Flow Growth	-3.18%	-14.35%	56.23%	-18.75%	107.32%	23.54%	Upgrade
Capital Expenditures	-226.7	-200.4	-204.7	-235	-259.8	-75.4	Upgrade
Acquisitions	0	0	-295.9	0	0	-1,154.2	Upgrade
Change in Investments	-2,979.8	-2,883.3	179.5	-105.9	359.2	-5.7	Upgrade
Other Investing Activities	-238	-58	-	-	-	-	Upgrade
Investing Cash Flow	-3,444.5	-3,141.7	-321.1	-340.9	99.4	-1,235.3	Upgrade
Share Issuance / Repurchase	-581.7	-519.1	14.3	-1,459.3	-474.5	151.2	Upgrade
Debt Issued / Paid	-45.7	-43.1	-82	-18.7	-29	-29.2	Upgrade
Other Financing Activities	2.4	-	-	-	-1.8	4.8	Upgrade
Financing Cash Flow	-625	-562.2	-67.7	-1,478	-505.3	126.8	Upgrade
Exchange Rate Effect	-0.7	26.9	-29.2	-13.4	20.6	1.6	Upgrade
Net Cash Flow	-126.2	-139.7	3,712	811.2	2,868	462.4	Upgrade
Free Cash Flow	3,717	3,337	3,925	2,409	2,994	1,494	Upgrade
Free Cash Flow Growth	-4.45%	-14.99%	62.97%	-19.55%	100.39%	27.16%	Upgrade
Free Cash Flow Margin	36.50%	33.81%	43.95%	31.80%	48.24%	35.89%	Upgrade
Free Cash Flow Per Share	14.40	12.95	15.33	9.35	11.52	5.82	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).